S
688193
vs
S
Shanghai Composite
Over the past 12 months, Shanghai Rendu Biotechnology Co Ltd has outperformed Shanghai Composite, delivering a return of +31% compared to the Shanghai Composite's +22% growth.
Stocks Performance
688193 vs Shanghai Composite
Performance Gap
688193 vs Shanghai Composite
Performance By Year
688193 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shanghai Rendu Biotechnology Co Ltd
Glance View
Shanghai Rendu Biotechnology Co., Ltd. develops molecular diagnostic tests. The company is headquartered in Shanghai, Shanghai and currently employs 528 full-time employees. The company went IPO on 2022-03-30. The firm utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The firm also designs and manufactures medical instruments. The firm mainly sells its products within domestic market.